Starboard Value, an activist investor, has taken a roughly $1 billion stake in Pfizer (PFE), pushing for significant changes to the struggling drugmaker. The investment comes as Pfizer's stock has fallen sharply since it reached record highs in 2021 during the rollout of its COVID-19 vaccine.
The move by Starboard Value is seen as an attempt to turn around Pfizer, which has been facing declining demand for COVID-19 treatments and other challenges. Analysts at various firms have maintained a hold rating on PFE stock, citing its consistent dividend history and growth potential despite the struggles. However, some analysts believe that Pfizer's stock should be held due to valuation concerns.
Pfizer CEO Albert Bourla is set to meet with Starboard Value in coming days amid growing pressure to revitalize the pharmaceutical giant's struggling share price and refine its strategic focus. The meeting comes as investors cheer the news of the investment, hoping it will spark a turnaround for the company.
The acquisition by Starboard Value has led to an increase in Pfizer stock prices, with shares rising more than 3% on Wednesday following reports that Bourla is scheduled to meet with executives from activist hedge fund Starboard Value next week. The meeting and investment come as investors look for signs of a plausible turnaround at the struggling pharmaceutical giant.
9-Oct-2024 5:19 PM CST - The Motley Fool Why Pfizer Stock Popped Today Pfizer (NYSE: PFE) was a stock on the move Wednesday, and not because of any news generated by the healthcare company. Reports of a meeting between Pfizer's leader and an activist investor breathed life into the stock, which closed the day more than 3% higher in price. That gain well exceeded the 0.7% increase of the S&P 500 index.
9-Oct-2024 3:30 PM CST - Business Wire Pfizer Declares Fourth-Quarter 2024 Dividend Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.42 fourth-quarter 2024 dividend on the companys common stock, payable December 2, 2024, to holders of the Common Stock of record at the close of business on November 8, 2024. The fourth-quarter 2024 cash dividend will be the 344th consecutive quarterly dividend paid by Pfizer. About Pfizer: Breakthroughs That Change Patients Lives At Pfizer, we apply science and our global resources to
9-Oct-2024 11:52 AM CST - Investing Pfizer gains as CEO said to meet activist Starboard Investing.com -- Pfizer Inc. (NYSE: PFE) shares rose more than 3% on Wednesday following reports that CEO Albert Bourla is scheduled to meet with executives from activist hedge fund Starboard Value next week.
9-Oct-2024 6:00 AM CST - Forbes What's Happening With Pfizer Stock? Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent years.
9-Oct-2024 3:55 AM CST - The Motley Fool As a Billionaire Activist Takes a Stake, Is Now the Time to Buy Pfizer Stock? Shares of Pfizer (NYSE: PFE) have been stuck in the mud since December 2022, with its shares down more than 45% over that stretch. Despite its underwhelming performance, many individual investors are attracted to the drug giant's robust dividend,
Starboard Value, an activist investor, has taken a roughly $1 billion stake in Pfizer (PFE), pushing for significant changes to the struggling drugmaker. The investment comes as Pfizer's stock has fallen sharply since it reached record highs in 2021 during the rollout of its COVID-19 vaccine.
The move by Starboard Value is seen as an attempt to turn around Pfizer, which has been facing declining demand for COVID-19 treatments and other challenges. Analysts at various firms have maintained a hold rating on PFE stock, citing its consistent dividend history and growth potential despite the struggles. However, some analysts believe that Pfizer's stock should be held due to valuation concerns.
Pfizer CEO Albert Bourla is set to meet with Starboard Value in coming days amid growing pressure to revitalize the pharmaceutical giant's struggling share price and refine its strategic focus. The meeting comes as investors cheer the news of the investment, hoping it will spark a turnaround for the company.
The acquisition by Starboard Value has led to an increase in Pfizer stock prices, with shares rising more than 3% on Wednesday following reports that Bourla is scheduled to meet with executives from activist hedge fund Starboard Value next week. The meeting and investment come as investors look for signs of a plausible turnaround at the struggling pharmaceutical giant.
9-Oct-2024 5:19 PM CST - The Motley Fool Why Pfizer Stock Popped Today Pfizer (NYSE: PFE) was a stock on the move Wednesday, and not because of any news generated by the healthcare company. Reports of a meeting between Pfizer's leader and an activist investor breathed life into the stock, which closed the day more than 3% higher in price. That gain well exceeded the 0.7% increase of the S&P 500 index.
9-Oct-2024 3:30 PM CST - Business Wire Pfizer Declares Fourth-Quarter 2024 Dividend Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.42 fourth-quarter 2024 dividend on the companys common stock, payable December 2, 2024, to holders of the Common Stock of record at the close of business on November 8, 2024. The fourth-quarter 2024 cash dividend will be the 344th consecutive quarterly dividend paid by Pfizer. About Pfizer: Breakthroughs That Change Patients Lives At Pfizer, we apply science and our global resources to
9-Oct-2024 11:52 AM CST - Investing Pfizer gains as CEO said to meet activist Starboard Investing.com -- Pfizer Inc. (NYSE: PFE) shares rose more than 3% on Wednesday following reports that CEO Albert Bourla is scheduled to meet with executives from activist hedge fund Starboard Value next week.
9-Oct-2024 6:00 AM CST - Forbes What's Happening With Pfizer Stock? Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent years.
9-Oct-2024 3:55 AM CST - The Motley Fool As a Billionaire Activist Takes a Stake, Is Now the Time to Buy Pfizer Stock? Shares of Pfizer (NYSE: PFE) have been stuck in the mud since December 2022, with its shares down more than 45% over that stretch. Despite its underwhelming performance, many individual investors are attracted to the drug giant's robust dividend,
